Advertisement

ADVERTISEMENT

lung cancer

News
First Patient Enrolled in the Phase 3 ELUCIDATE Trial of Pafolacianine Sodium (formerly OTL38) in the Intraoperative Identification of Lung Cancer Lesions
08/06/2020

On Target Laboratories, Inc.

On Target Laboratories, Inc.
WEST LAFAYETTE, Ind., July 8, 2020 /PRNewswire/ -- On Target Laboratories, Inc., a privately-held biotechnology company developing fluorescent markers to target and illuminate cancer during surgery, has announced that it has...
WEST LAFAYETTE, Ind., July 8, 2020 /PRNewswire/ -- On Target Laboratories, Inc., a privately-held biotechnology company developing fluorescent markers to target and illuminate cancer during surgery, has announced that it has...
WEST LAFAYETTE, Ind., July 8,...
08/06/2020
IO Learning
News
Do Facility Demographics Impact Outcomes in NSCLC Patients Treated With Radiofrequency Ablation?
10/21/2018
A new study sought to determine if patient and facility demographics impacted overall survival in patients with early-stage non-small cell lung cancer (NSCLC) treated with radiofrequency (RF) ablation. Results published in the Journal of...
A new study sought to determine if patient and facility demographics impacted overall survival in patients with early-stage non-small cell lung cancer (NSCLC) treated with radiofrequency (RF) ablation. Results published in the Journal of...
A new study sought to determine...
10/21/2018
IO Learning
News
Radiofrequency Ablation vs Stereotactic Body Radiotherapy in NSCLC
08/19/2018
A new study found no significant difference in overall survival (OS) for patients with early-stage non–small cell lung cancer (NSCLC) treated with either radiofrequency (RF) ablation or stereotactic body radiotherapy (SBRT). The study was...
A new study found no significant difference in overall survival (OS) for patients with early-stage non–small cell lung cancer (NSCLC) treated with either radiofrequency (RF) ablation or stereotactic body radiotherapy (SBRT). The study was...
A new study found no significant...
08/19/2018
IO Learning
The Case for Lung Ablation
07/19/2018
Interventional oncologists often report that they have difficulty making the case for continuing to perform lung ablation, but many clinicians are convinced that lung ablation should remain within the scope of practice. Alice Gillams, MB,...
Interventional oncologists often report that they have difficulty making the case for continuing to perform lung ablation, but many clinicians are convinced that lung ablation should remain within the scope of practice. Alice Gillams, MB,...
Interventional oncologists often...
07/19/2018
IO Learning
News
Lung Cancer: Do High-Volume Centers Lead to Better Overall Survival?
03/20/2018
LOS ANGELES—Treating lung cancer with radiofrequency ablation (RFA) at high-volume centers is linked with improved overall survival, researchers reported in a study presented at the annual meeting of the Society of Interventional Radiology....
LOS ANGELES—Treating lung cancer with radiofrequency ablation (RFA) at high-volume centers is linked with improved overall survival, researchers reported in a study presented at the annual meeting of the Society of Interventional Radiology....
LOS ANGELES—Treating lung cancer...
03/20/2018
IO Learning
CIO and Lung Ablation: A Collective Exhale of Information
02/04/2018
Morning sessions review lung ablation therapies and potential for emerging technologies. By Brenda Silva As CIO 2018 continues, early sessions on day two looked to report on existing and emerging technologies for ablation with focused...
Morning sessions review lung ablation therapies and potential for emerging technologies. By Brenda Silva As CIO 2018 continues, early sessions on day two looked to report on existing and emerging technologies for ablation with focused...
Morning sessions review lung...
02/04/2018
IO Learning
Lung Ablation Year in Review
01/25/2018
Lung ablation is an active area of research in interventional oncology, and recently published studies have given clinicians more factors to consider when determining which patients are good candidates for the procedure. In this Q&A, Stephen...
Lung ablation is an active area of research in interventional oncology, and recently published studies have given clinicians more factors to consider when determining which patients are good candidates for the procedure. In this Q&A, Stephen...
Lung ablation is an active area...
01/25/2018
IO Learning
News
Radiofrequency or microwave ablation for treatment of the lung tumors?
05/02/2017
In a prospective multi-centre randomized trial by Machi et al published in the Journal Medical Oncology (2017 May 10.1007/s12032-017-0946-x), radiofrequency ablation (RFA) and microwave ablation (MWA) are both found to be excellent in...
In a prospective multi-centre randomized trial by Machi et al published in the Journal Medical Oncology (2017 May 10.1007/s12032-017-0946-x), radiofrequency ablation (RFA) and microwave ablation (MWA) are both found to be excellent in...
In a prospective multi-centre...
05/02/2017
IO Learning
News
SBRT Improves Survival for Elderly Early-Stage Lung Cancer Patients
09/28/2016
Newswise — BOSTON, September 26, 2016 -- Survival rates for elderly patients who received stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) rose from roughly 40% to 60% over the past decade,...
Newswise — BOSTON, September 26, 2016 -- Survival rates for elderly patients who received stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) rose from roughly 40% to 60% over the past decade,...
Newswise — BOSTON, September 26,...
09/28/2016
IO Learning
News
Advances in Radiation Therapy Have Improved Survival Rates for Early Stage Lung Cancer Patients
09/27/2016
Newswise — BOSTON, September 25, 2016 -- A new analysis of records in the Veteran’s Affairs Central Cancer Registry demonstrates a clear positive impact of the increased use of stereotactic body radiation therapy (SBRT) to treat patients with...
Newswise — BOSTON, September 25, 2016 -- A new analysis of records in the Veteran’s Affairs Central Cancer Registry demonstrates a clear positive impact of the increased use of stereotactic body radiation therapy (SBRT) to treat patients with...
Newswise — BOSTON, September 25,...
09/27/2016
IO Learning

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

Psych Congress Regionals
July 18 ⁠–⁠ July 19
Advances in Inflammatory Bowel Disease Regionals
July 19 ⁠–⁠ July 20
July 24 ⁠–⁠ July 26
APP Institute Inflammatory Bowel Disease
July 26 ⁠–⁠ July 27
July 27 ⁠–⁠ July 28
July 27 ⁠–⁠ July 28
Psych Congress Regionals
August 8 ⁠–⁠ August 9
August 14 ⁠–⁠ August 17
August 16 ⁠–⁠ August 18
APP Institute Dermatology
August 16 ⁠–⁠ August 17
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use